EGFR and colorectal carcinoma: Genetic alterations and concurrent alterations of c-MET/EGFR with other genetic alterations have been well reported in lung cancer (Stuart and Sellers, 2009; Tang et al., 2018; Guo et al., 2020b; Gini et al., 2020), but were underreported in other solid cancers especially CRC, and hence our study is significant in this regard.